MedTrace Logo

MOTIV Bioresorbable Scaffold in BTK Artery Disease

NCT03987061 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2023-03-17

No results posted yet for this study

Summary

The objective of this clinical evaluation is to evaluate the immediate and long-term (up to 36 months) outcome of the MOTIV™ Bioresorbable Scaffold (Reva Medical) in a controlled prospective investigation for the treatment of patients with rest pain or minor tissue loss (CLI) due to the presence of lesions of max 100mm in length at the level of the below-the-knee arteries.

Conditions

  • Peripheral Arterial Disease
  • Critical Limb Ischemia

Interventions

DEVICE

MOTIV BVS

MOTIVS BVS in below-the-knee artery disease

Sponsors & Collaborators

  • Dr. Sabrina Overhagen

    lead OTHER

Principal Investigators

  • Giovanni Torsello, Prof. Dr. · Foundation for Cardiovascular Research and Education

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-05
Primary Completion
2022-07-01
Completion
2024-07-01

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03987061 on ClinicalTrials.gov